MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
AVBP — ArriVent BioPharma, Inc. Common Stock
NasdaqArriVent BioPharma, Inc. Common Stock
$28.27
-0.66(-2.28%)
- O
- 29.26
- H
- 29.33
- L
- 27.80
- V
- 507.4K
⏱️ End-of-day dataAs of Oct 2, 2026
AVBP — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $62.10M | $45.54M | $11.27M | $11.28M | $49.87M | $74.29M |
| Other Short Term Investments | $26.43M | $26.73M | $18.76M | $12.29M | $12.62M | $14.46M |
| Prepaid Assets | $1.43M | 186,000.00 | 552,000.00 | 787,000.00 | N/A | $7.62M |
| Other Current Assets | $20.89M | $19.83M | $19.89M | $13.17M | $9.20M | $7.62M |
| Total Current Assets | $34.87M | $33.29M | $32.12M | $25.01M | $18.58M | $22.70M |
| Properties | 370,000.00 | 0.00 | 49,000.00 | 85,000.00 | 120,000.00 | 0.00 |
| Other Non Current Assets | 225,000.00 | 259,000.00 | 180,000.00 | 479,000.00 | 176,000.00 | 126,000.00 |
| Total Non Current Assets | 595,000.00 | 272,000.00 | $5.34M | $19.36M | $29.71M | $47.96M |
| Total Assets | $34.93M | $33.32M | $32.66M | $26.95M | $21.55M | $27.49M |
| Accounts Payable | $8.73M | $5.93M | $5.93M | $4.06M | $4.36M | $3.78M |
| Accrued Expenses | $14.24M | $13.45M | $11.18M | $12.69M | $6.90M | $9.17M |
| Short Term Debt | 99,000.00 | 14,000.00 | 56,000.00 | 98,000.00 | 138,000.00 | 162,000.00 |
| Pensions | $1.93M | $6.54M | $4.39M | $2.79M | $1.55M | $4.16M |
| Total Current Liabilities | $25.00M | $25.95M | $21.56M | $19.64M | $12.95M | $17.27M |
| Long Term Debt | 320,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14,000.00 |
| Total Non Current Liabilities | 320,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14,000.00 |
| Total Liabilities | $25.32M | $25.95M | $21.56M | $19.64M | $12.95M | $17.29M |
| Common Stock | 5,000.00 | 4,000.00 | 4,000.00 | 4,000.00 | 4,000.00 | 3,000.00 |
| Retained Earnings | $-44.80M | $-40.46M | $-36.91M | $-33.41M | $-30.27M | $-23.83M |
| Other Shareholders Equity | -270,000.00 | 14,000.00 | 206,000.00 | -18,000.00 | -17,000.00 | -211,000.00 |
| Total Shareholders Equity | $32.40M | $30.72M | $30.50M | $24.99M | $20.25M | $25.77M |
| Additional Paid In Capital | $77.22M | $71.18M | $67.39M | $58.40M | $50.53M | $49.62M |
| Other Receivables | N/A | 60,000.00 | N/A | N/A | N/A | N/A |
| Investments And Advances | N/A | 0.00 | $5.11M | $18.79M | $29.41M | $47.68M |